Literature DB >> 9357488

Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador.

R H Guderian1, M Anselmi, M Espinel, T Mancero, G Rivadeneira, R Proaño, H M Calvopiña, J C Vieira, P J Cooper.   

Abstract

Onchocerciasis is a major blinding disease in equatorial Africa and Central and South America. Ivermectin is a safe and effective drug in the treatment of this disease and now forms the basis of disease control in most endemic areas. We report the findings of long-term control of this infection in the Río Santiago focus in Ecuador, between January 1990 and December 1996, using a strategy of giving ivermectin treatments biannually in hyperendemic communities and annually in meso- and hypoendemic communities. Ivermectin was administered by local health workers from each community. A high level of compliance to ivermectin was achieved, with 81.9% to 98.0% of those eligible receiving the drug at each treatment instance. The impact of ivermectin therapy was monitored using a cohort of 120 randomly selected infected individuals from 8 hyperendemic communities. The geometric mean microfilarial density of this group declined from 19.3 to 0 mf/mg over the 84-month observation period. Ivermectin had a significant impact on anterior segment ocular disease, acute onchodermatitis and sowda. The rate of infection of blackflies declined from 1.1% in 1989-0.08% in 1996, which is below the vectorial capacity of the Simulium vector and, as no new nodules were detected after 1994 and no children under 5 became infected over the observation period, it is likely that the transmission of this infection was interrupted in the study area.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357488     DOI: 10.1046/j.1365-3156.1997.d01-158.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

1.  Human onchocerciasis and tetanus vaccination: impact on the postvaccination antitetanus antibody response.

Authors:  P J Cooper; I Espinel; M Wieseman; W Paredes; M Espinel; R H Guderian; T B Nutman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  In vitro activities of plant extracts on human Loa loa isolates and cytotoxicity for eukaryotic cells.

Authors:  Line-Edwige Mengome; Jean Paul Akue; Alain Souza; Guy Raymond Feuya Tchoua; Edouard Nsi Emvo
Journal:  Parasitol Res       Date:  2010-05-22       Impact factor: 2.289

Review 3.  Drug treatment of tropical parasitic infections: recent achievements and developments.

Authors:  I Stephenson; M Wiselka
Journal:  Drugs       Date:  2000-11       Impact factor: 11.431

4.  Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.

Authors:  W S Alley; G J van Oortmarssen; B A Boatin; N J Nagelkerke; A P Plaisier; J H Remme; J Lazdins; G J Borsboom; J D Habbema
Journal:  BMC Public Health       Date:  2001-11-06       Impact factor: 3.295

5.  Evaluating the diagnostic test accuracy of molecular xenomonitoring methods for characterising the community burden of Onchocerciasis.

Authors:  Joseph Pryce; Thomas R Unnasch; Lisa J Reimer
Journal:  PLoS Negl Trop Dis       Date:  2021-10-12

6.  Time series analysis of onchocerciasis data from Mexico: a trend towards elimination.

Authors:  Edgar E Lara-Ramírez; Mario A Rodríguez-Pérez; Miguel A Pérez-Rodríguez; Monsuru A Adeleke; María E Orozco-Algarra; Juan I Arrendondo-Jiménez; Xianwu Guo
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14

7.  Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection.

Authors:  Juan Carlos Vieira; Philip J Cooper; Raquel Lovato; Tamara Mancero; Jorge Rivera; Roberto Proaño; Andrea A López; Ronald H Guderian; José Rumbea Guzmán
Journal:  BMC Med       Date:  2007-05-23       Impact factor: 8.775

8.  Contribution of migrant coffee labourers infected with Onchocerca volvulus to the maintenance of the microfilarial reservoir in an ivermectin-treated area of Mexico.

Authors:  Mario A Rodríguez-Pérez; Aldo Segura Cabrera; Cristian Lizarazo Ortega; María-Gloria Basáñez; John B Davies
Journal:  Filaria J       Date:  2007-12-18

9.  Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.

Authors:  Mariella Anselmi; Dora Buonfrate; Angel Guevara Espinoza; Rosanna Prandi; Monica Marquez; Maria Gobbo; Antonio Montresor; Marco Albonico; Marcia Racines Orbe; Juan Martin Moreira; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2015-11-05

10.  Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.

Authors:  Jérémy T Campillo; Cédric B Chesnais; Sébastien D S Pion; Jacques Gardon; Joseph Kamgno; Michel Boussinesq
Journal:  Parasit Vectors       Date:  2020-05-15       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.